저자들은 절제 불가능한 국소진행형 췌장암 환자가 동시 적 항암화학방사선요법 및 gemcitabine 유지 항암화학요법을 받은 후 장기간 동안 완전 관해를 유지하고 있는 증례를 보고하는 바이다. 이 증례를 통해 다른 절제 불가능한 국소 진행형 췌장암 환자들에게도 동시적 항암화학방사선요법 및 gemcitabine 유지 항암화학요법 치료를 시도해 볼 수 있을 것이다.

Locally advanced or metastatic disease accounts for two thirds of total patients with pancreatic cancer. Patients with pancreatic cancer are assessed as resectable, potentially resectable (borderline) or unresectable according to pre-operative examinations. The chances of resectability may be enhanced by using neoadjuvant systemic chemotherapy, radiotherapy or both. This case report presents a locally advanced pancreatic adenocarcinoma that was identified to be unresectable during surgical exploration. After receiving concurrent chemoradiotherapy, the patient was re-evaluated, identified as unresectable and received gemcitabine maintenance chemotherapy. Herein, we report the case of a patient with unresectable locally advanced pancreatic adenocarcinoma who achieved a complete response lasting for more than 32 months after receiving concurrent chmoradiotherapy followed by gemcitabine maintenance chemotherapy.

• 양재윤(중앙보훈병원 내과) | Jaeyun Yang
• 임태규(중앙보훈병원 내과) | Taekyu Lim Corresponding author
• 김태균(중앙보훈병원 내과) | Taegyoon Kim
• 한승문(중앙보훈병원 내과) | Seungmoon Han
• 이상희(중앙보훈병원 내과) | Sanghee Lee
• 김희서(중앙보훈병원 내과) | Huiseo Kim
• 이지원(중앙보훈병원 내과) | Jiwon Lee
• 안성영(중앙보훈병원 내과) | Seongyeong Ahn